Submitted by Anonymous (not verified) on 15 January 2025 - 14:13
Orphan designation: 4-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-amine Treatment of neurofibromatosis type 2, 13/12/2024 Positive
Source:
Orphan designation: 4-(4-(2-(Diethylamino)ethoxy)phenyl)-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-amine Treatment of neurofibromatosis type 2, 13/12/2024 Positive